Publications found:
36,576
Sort by:
IgA Nephropathy Drugs Market - 2024-2031
US$ 3,400.00
IgA Nephropathy Drugs Marketis is growing with a CAGR of 18.10% during the forecast period 2026-2035. The IgA Nephropathy Drugs Market emerges as a key focus in DataM Intelligence latest in-depth anal...
March 2025
47 pages
Clinical Trial Services Market by Type (Laboratory, Monitoring, Recruitment, PV, Data Management), Phase (I, II, III), Therapy (Oncology, Neurology, Dermatology, CVD), Modality (Biologics, Devices), Delivery Model (FSP, Hybrid) - Global Forecast to 2030
US$ 2,970.00
The global clinical trial services market is projected to reach USD 101.86 billion in 2030 from USD 66.59 billion in 2025, growing at a CAGR of 8.9% during the forecast period. This market is expandin...
March 2025
522 pages
Leukemia Market - 2024-2031
US$ 3,400.00
Leukemia Marketis is growing with a CAGR of 8.90% during the forecast period 2026-2035. The Leukemia Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned resear...
March 2025
34 pages
Polycystic Ovary Syndrome Market - 2024-2031
US$ 3,400.00
Polycystic Ovary Syndrome Marketis is growing with a CAGR of 5.50% during the forecast period 2026-2035. The Polycystic Ovary Syndrome Market emerges as a key focus in DataM Intelligence latest in-dep...
March 2025
51 pages
Albumin Pharmaceutical Preparations Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application
US$ 3,200.00
Albumin Pharmaceutical Preparations Market Albumin pharmaceutical preparations, derived from human plasma, are critical biologics used to restore blood volume, manage hypoalbuminemia, and support var...
March 2025
77 pages
Clonazepam Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type
US$ 3,200.00
Clonazepam Market Clonazepam is a benzodiazepine medication used to treat anxiety disorders, panic attacks, and seizures, available in tablet and injectable forms. It enhances GABA activity, offering...
March 2025
104 pages
Desmopressin (DDAVP) Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type
US$ 3,200.00
Desmopressin (DDAVP) Market Desmopressin (DDAVP), a synthetic analog of vasopressin, is a versatile pharmaceutical used to regulate water balance and manage bleeding disorders. Available in tablets,...
March 2025
96 pages
Enuresis Treatment Drug Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type
US$ 3,200.00
Enuresis Treatment Drug Market Enuresis Treatment Drugs address nocturnal enuresis (bedwetting), available as desmopressin, imipramine hydrochloride, and others like oxybutynin and hyoscyamine. These...
March 2025
114 pages
Hyoscyamine Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type
US$ 3,200.00
Hyoscyamine Market Hyoscyamine is an anticholinergic drug used to treat gastrointestinal disorders, spasms, and enuresis, available in oral and injectable forms. It blocks acetylcholine, relieving mu...
March 2025
73 pages
Pharmaceutical Suspension Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type
US$ 3,200.00
Pharmaceutical Suspension Market Pharmaceutical suspensions are liquid formulations where insoluble active ingredients are dispersed, widely used for antibiotics, antacids, and pediatric drugs. Their...
March 2025
90 pages
Hepatitis A Vaccine Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type
US$ 3,200.00
Hepatitis A Vaccine Market Hepatitis A vaccines, using inactivated virus, prevent liver infection and are vital in public health programs. The market operates within the vaccine sector, driven by tra...
March 2025
85 pages
Pharmaceutical Excipient Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type
US$ 3,200.00
Pharmaceutical Excipient Market Pharmaceutical Excipients are inactive substances used in drug formulations to enhance stability, bioavailability, and manufacturability, serving as critical component...
March 2025
134 pages
Global Gaucher Disease Treatment Market - 2025-2033
US$ 3,400.00
Global Gaucher Disease Treatment Marketis is growing with a CAGR of 2.90% during the forecast period 2026-2035. The Global Gaucher Disease Treatment Market emerges as a key focus in DataM Intelligence...
March 2025
58 pages
Hurler Syndrome Treatment Market - 2025-2033
US$ 3,400.00
Hurler Syndrome Treatment Market reached US$ 377.65 million in 2024 and is expected to reach US$ 529.34 million by 2033, growing with a CAGR of 3.90% during the forecast period 2026-2033. The Hurler S...
March 2025
51 pages
Hydronephrosis Market - 2024-2031
US$ 3,400.00
Hydronephrosis Marketis is growing with a CAGR of 9.50% during the forecast period 2026-2035. The Hydronephrosis Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where sea...
March 2025
40 pages
Alpha Thalassemia Market - 2024-2031
US$ 3,400.00
Alpha Thalassemia Market reached US$ 1.1 billion in 2022 and is expected to reach US$ 1.9 billion by 2031, growing with a CAGR of 7.40% during the forecast period 2026-2031. The Alpha Thalassemia Mark...
March 2025
43 pages
Antimicrobial Therapeutics Market Size, Share, and Analysis, By Drug Class (Antibacterial, Antivirals, Antifungal, and Antiparasitic), By Route of Administration (Oral, Tropic, Injectable, and Others), By Disease Indication (Respiratory Infections, Urinary Tract Infections, Skin and Soft Tissue Infections, Sexually Transmitted Infections, Gastrointestinal Infections, Central Nervous System Infections, and Others), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
US$ 5,250.00
Antimicrobial Therapeutics Market Size, Share, and Analysis, By Drug Class (Antibacterial, Antivirals, Antifungal, and Antiparasitic), By Route of Administration (Oral, Tropic, Injectable, and Others)...
March 2025
406 pages
Cognitive and Memory Enhancer Drugs Market Report by Product (Aricept, Exelon, Namenda, Razadyne, Provigil, Ritalin, Adderall, and Others), Application (Disease Treatment, Athletic Performance, Academic Performance, and Others), and Region 2025-2033
US$ 2,999.00
The global cognitive and memory enhancer drugs market size reached USD 6,171.6 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 9,460.6 Million by 2033, exhibiting a growt...
March 2025
139 pages
Depression Drugs Market Report by Drug Class (Atypical Antipsychotics, Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), Selective Serotonin Reuptake Inhibitors (SSRIs), Central Nervous System (CNS) Stimulants, Tricyclic Antidepressants, Monoamine Oxidase Inhibitors, and Others), Disorder Type (Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder, and Others), Drug Type (Generic Drugs, Branded Drugs), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Region 2025-2033
US$ 2,999.00
The global depression drugs market size reached USD 19.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 25.1 Billion by 2033, exhibiting a growth rate (CAGR) of 2.9% dur...
March 2025
148 pages
Heparin Market Size, Share, Trends and Forecast by Product, Source, Mode of Administration, Application, End-User, Distribution Channel, and Region 2025-2033
US$ 2,999.00
The global heparin market size was valued at USD 7.46 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 9.02 Billion by 2033, exhibiting a CAGR of 2.12% during 2025-2033....
March 2025
145 pages
Infectious Disease Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents), By Technology (Mass Spectrometry, PCR, In Situ Hybridization), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030
US$ 5,950.00
This report can be delivered to the clients within Immediate Infectious Disease Molecular Diagnostics Market Growth & Trends The global infectious disease molecular diagnostics market size is expect...
February 2025
100 pages
Albendazole Anthelmintic Drug Market - 2024-2031
US$ 3,400.00
Albendazole Anthelmintic Drug Marketis is growing with a CAGR of 6.50% during the forecast period 2026-2035. The Albendazole Anthelmintic Drug Market emerges as a key focus in DataM Intelligence lates...
February 2025
55 pages
Hypovolemic Shock Market - 2024-2031
US$ 3,400.00
The Hypovolemic Shock Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unpara...
February 2025
43 pages
Acute Coronary Syndrome Market - 2024-2031
US$ 3,400.00
Acute Coronary Syndrome Market reached US$ 9.94 billion in 2023 and is expected to reach US$ 14.70 billion by 2031, growing with a CAGR of 5.10% during the forecast period 2026-2031. The Acute Coronar...
February 2025
49 pages
Chronic Lymphocytic Leukemia Market - 2025-2033
US$ 3,400.00
Chronic Lymphocytic Leukemia Market reached US$ 5.7 billion in 2024 and is expected to reach US$ 9.1 billion by 2033, growing with a CAGR of 5.50% during the forecast period 2026-2033. The Chronic Lym...
February 2025
54 pages
Imatinib Drug Market - 2024-2031
US$ 3,400.00
The Imatinib Drug Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparallel...
February 2025
39 pages
Breast Imaging Market - 2025-2033
US$ 3,400.00
Breast Imaging Market reached US$ 4.74 billion in 2024 and is expected to reach US$ 9.77 billion by 2033, growing with a CAGR of 8.43% during the forecast period 2026-2033. The Breast Imaging Market e...
February 2025
40 pages
Hypereosinophilic Syndrome Market - 2024-2031
US$ 3,400.00
Hypereosinophilic Syndrome Marketis is growing with a CAGR of 8.60% during the forecast period 2026-2035. The Hypereosinophilic Syndrome Market emerges as a key focus in DataM Intelligence latest in-d...
February 2025
52 pages
